Open in Screener

PBYI

Puma Biotechnology Inc

Jun 15 • 04:00PM ET

7.07

-0.26 -3.55 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NKTR KROS INCY VKTX BMRN KRYS RYTM AXSM MDGL NBIX

| Held by: AVUV VTI IWM VXF IWN VTWO BSVO FESM DFAT DFAS

Index	RUT	P/E	14.81	EPS (ttm)	0.48	Insider Own	23.49%	Shs Outstand	50.88M	Perf Week	3.21%
Market Cap	359.86M	Forward P/E	35.35	EPS next Y	0.20	Insider Trans	-1.11%	Shs Float	38.94M	Perf Month	-1.67%
Enterprise Value	272.17M	PEG	-	EPS next Q	0.04	Inst Own	66.69%	Short Float	9.77%	Perf Quarter	16.47%
Income	24.38M	P/S	1.58	EPS this Y	-52.46%	Inst Trans	6.38%	Short Ratio	14.67	Perf Half Y	23.39%
Sales	227.18M	P/B	2.80	EPS next Y	-31.03%	ROA	12.54%	Short Interest	3.80M	Perf YTD	18.82%
Book/sh	2.52	P/C	3.47	EPS next 5Y	-	ROE	21.62%	52W High	7.90 -10.49%	Perf Year	111.04%
Cash/sh	2.04	P/FCF	6.71	EPS past 3/5Y	- -	ROIC	18.34%	52W Low	3.03 133.33%	Perf 3Y	99.15%
Dividend Est.	-	EV/EBITDA	6.78	Sales past 3/5Y	0.05% 0.29%	Gross Margin	74.46%	Volatility	4.49% 3.76%	Perf 5Y	-33.18%
Dividend TTM	-	EV/Sales	1.20	EPS Y/Y TTM	-37.13%	Oper. Margin	12.98%	ATR (14)	0.29	Perf 10Y	-78.07%
Dividend Ex-Date	-	Quick Ratio	2.24	Sales Y/Y TTM	-2.38%	Profit Margin	10.73%	RSI (14)	48.88	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.38	EPS Q/Q	-223.83%	SMA20	0.12%	Beta	1.20	Target Price	5.00
Payout	0.00%	Debt/Eq	0.12	Sales Q/Q	-2.59%	SMA50	-2.52%	Rel Volume	0.68	Prev Close	7.33
Employees	179	LT Debt/Eq	0.04	Earnings	May 07 AMC	SMA200	16.01%	Avg Volume	259.32K	Price	7.07
IPO	Apr 20, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	58.82% 6.67%	Trades		Volume	177,367	Change	-3.55%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-28-21	Upgrade	Citigroup	Neutral → Buy	$11
Jun-25-20	Resumed	BofA/Merrill	Underperform	$9
Oct-08-19	Downgrade	Goldman	Neutral → Sell	$24 → $8
May-10-19	Downgrade	Citigroup	Buy → Neutral	$24
May-10-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$57 → $20
Jan-17-19	Initiated	Leerink Partners	Mkt Perform	$21
Jan-03-19	Downgrade	Guggenheim	Buy → Neutral
Nov-19-18	Upgrade	Goldman	Sell → Neutral
Nov-02-18	Downgrade	JP Morgan	Neutral → Underweight
Nov-02-18	Downgrade	BofA/Merrill	Buy → Underperform
Oct-01-18	Initiated	Cantor Fitzgerald	Overweight	$75
Sep-17-18	Initiated	Goldman	Sell	$42
May-11-18	Reiterated	Stifel	Buy	$95 → $87
Nov-10-17	Reiterated	RBC Capital Mkts	Sector Perform	$92 → $108
Nov-10-17	Reiterated	Citigroup	Buy	$156 → $164
Oct-02-17	Reiterated	Stifel	Buy	$110 → $130
Sep-11-17	Reiterated	Credit Suisse	Outperform	$118 → $136
Jul-10-17	Resumed	Leerink Partners	Outperform	$115
Jun-06-17	Reiterated	RBC Capital Mkts	Sector Perform	$60 → $88
May-25-17	Reiterated	RBC Capital Mkts	Sector Perform	$40 → $60

Show Previous Ratings

Jun-03-26 05:00PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-08-26 08:30AM	Puma Biotechnology, Inc. Q1 2026 Earnings Call Summary (Moby)
May-07-26 05:37PM	Puma Biotech: Q1 Earnings Snapshot (Associated Press)
04:05PM	Puma Biotechnology Reports First Quarter 2026 Financial Results (Business Wire)
May-06-26 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
04:15PM	Loading…
Apr-23-26 04:15PM	Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results (Business Wire)
Apr-02-26 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-27-26 12:35PM	PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View (Zacks) -25.00%
08:30AM	Puma Biotechnology, Inc. Q4 2025 Earnings Call Summary (Moby)
01:12AM	Puma Biotechnology Q4 Earnings Call Highlights (MarketBeat)
12:05AM	Puma Biotechnology Inc (PBYI) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
Feb-26-26 06:45PM	Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates (Zacks)
05:15PM	Puma Biotech: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-24-26 07:30PM	Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates (Zacks) +5.34%
04:15PM	Loading…
Feb-23-26 04:15PM	Puma Biotechnology to Present at TD Cowens 46th Annual Health Care Conference (Business Wire)
Feb-12-26 04:07PM	Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Feb-10-26 05:25PM	Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-04-26 05:05PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-07-26 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-31-25 11:20AM	Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag? (Barchart)
Dec-22-25 04:10PM	Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) (Business Wire)
Dec-17-25 11:26AM	CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? (Zacks)
Dec-02-25 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.57%
Nov-27-25 11:58AM	IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? (Zacks)
Nov-07-25 05:05PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +22.24% -21.04%
10:53AM	PBYI's Q3 Earnings & Revenues Beat Estimates, 2025 Sales View Raised (Zacks)
12:03AM	Puma Biotechnology Inc (PBYI) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Royalty ... (GuruFocus.com)
Nov-06-25 06:00PM	Puma Biotech (PBYI) Q3 Earnings and Revenues Top Estimates (Zacks)
04:55PM	Puma Biotech: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	Puma Biotechnology Reports Third Quarter 2025 Financial Results (Business Wire)
Nov-05-25 05:20PM	Acadia Pharmaceuticals (ACAD) Q3 Earnings and Revenues Top Estimates (Zacks)
Oct-23-25 04:10PM	Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results (Business Wire)
Oct-09-25 05:06AM	CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains? (Zacks)
Oct-02-25 05:21PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-17-25 02:27PM	What Do Analysts Think About Puma Biotechnology (PBYI)? (Insider Monkey)
Sep-15-25 12:42PM	PBYI Surges 30% in 3 Months: How Should You Play the Stock? (Zacks)
Sep-04-25 05:25PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-02-25 04:07PM	Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference (Business Wire)
Sep-01-25 09:55AM	Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks)
Aug-28-25 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Aug-13-25 09:15AM	Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue? (Zacks) +8.83%
Aug-12-25 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
09:15AM	Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out? (Zacks)
09:11AM	Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT (Insider Monkey)
Aug-08-25 05:00PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +12.16% +31.44%
10:26AM	PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues (Zacks)
Aug-07-25 05:55PM	Puma Biotech (PBYI) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:56PM	Puma Biotech: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports Second Quarter Financial Results (Business Wire)
Aug-06-25 06:05PM	Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-24-25 04:15PM	Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results (Business Wire)
Jul-15-25 08:31AM	Add These 4 Top-Ranked Liquid Stocks to Boost Portfolio Returns (Zacks)
Jul-14-25 09:40AM	Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? (Zacks)
Jul-10-25 08:50AM	Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors (Zacks)
Jul-08-25 10:31AM	Bayer Begins Phase I/II Study on Cell Therapy for Eye Disease (Zacks)
Jul-04-25 08:35AM	AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer (Zacks)
Jul-02-25 05:03PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:34AM	Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek (Zacks)
Jul-01-25 11:55AM	RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance (Zacks)
10:05AM	ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B (Zacks)
Jun-30-25 10:40AM	Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why (Zacks)
Jun-27-25 10:58AM	PFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal (Zacks)
09:40AM	Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? (Zacks)
Jun-25-25 11:30AM	NKTR Stock Soars as Lead Drug Meets Goal in Atopic Dermatitis Study (Zacks)
Jun-24-25 08:50AM	Fast-paced Momentum Stock Puma Biotech (PBYI) Is Still Trading at a Bargain (Zacks)
Jun-19-25 11:11AM	Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma (Zacks)
Jun-18-25 10:51AM	Bayer Seeks FDA Approval for MRI Contrast Agent Gadoquatrane (Zacks)
Jun-12-25 11:30AM	Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report? (Zacks)
Jun-11-25 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Jun-04-25 05:33PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +7.39%
May-28-25 08:50AM	Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors (Zacks)
May-26-25 09:40AM	Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? (Zacks)
May-12-25 08:50AM	Despite Fast-paced Momentum, Puma Biotech (PBYI) Is Still a Bargain Stock (Zacks)
May-09-25 09:40AM	Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? (Zacks) -5.21%
08:48AM	PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates (Zacks)
03:39AM	Puma Biotechnology Inc (PBYI) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges (GuruFocus.com)
May-08-25 05:55PM	Puma Biotech (PBYI) Q1 Earnings and Revenues Top Estimates (Zacks)
04:52PM	Puma Biotech: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Puma Biotechnology Reports First Quarter Financial Results (Business Wire)
May-07-25 05:20PM	Puma Biotechnology Q1 2025 Earnings Preview (Seeking Alpha)
01:25PM	Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y (Zacks)
11:55AM	JAZZ Misses Q1 Earnings & Sales Estimates, Cuts '25 EPS Outlook (Zacks)
08:10AM	Apellis Pharmaceuticals, Inc. (APLS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-06-25 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-05-25 09:15AM	ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? (Zacks)
May-01-25 08:05AM	Biogen Inc. (BIIB) Q1 Earnings Lag Estimates (Zacks)
Apr-30-25 12:00PM	Puma Biotech (PBYI) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
06:00AM	Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX (neratinib) for Breast Cancer Patients (GlobeNewswire)
Apr-28-25 03:03PM	Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025 (Business Wire)
Apr-24-25 04:11PM	Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results (Business Wire)
Apr-23-25 09:40AM	Should Value Investors Buy Puma Biotechnology (PBYI) Stock? (Zacks)
Apr-21-25 09:13AM	Is the Options Market Predicting a Spike in Puma Biotechnology Stock? (Zacks)
Apr-11-25 01:20PM	Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential (Seeking Alpha)
Apr-02-25 05:15PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-26-25 09:00AM	Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025 (Business Wire)
Mar-20-25 12:23PM	Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why (Zacks)
Mar-18-25 04:35AM	Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now (Insider Monkey)
Mar-05-25 06:05PM	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
05:30PM	Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference (Business Wire)

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

FounderMr. Alan H. Auerbach

CFO & Principal Accounting OfficerMr. Maximo F. Nougues

FRAPSMr. Douglas Hunt B.Sc.

Chief Accounting OfficerMr. Gordon G. Esplin

Senior Director of Investor RelationsMr. Mariann Ohanesian

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WILSON TROY EDWARD	Director	Jun 12 '26	Sale	7.20	10,800	77,748	59,750	Jun 15 08:16 PM
Stuglik Brian M	Director	Jun 12 '26	Sale	7.20	8,100	58,311	113,858	Jun 15 08:14 PM
Senderowicz Adrian	Director	Jun 12 '26	Sale	7.20	27,000	194,311	27,000	Jun 15 08:13 PM
MOYES JAY M	Director	Jun 12 '26	Sale	7.22	22,000	158,796	58,322	Jun 15 08:10 PM
Dorval Allison	Director	Jun 12 '26	Sale	7.20	11,610	83,579	90,780	Jun 15 08:09 PM
Senderowicz Adrian	Director	Jun 12 '26	Proposed Sale	7.26	27,000	196,020		Jun 12 10:39 AM
MOYES JAY M	Director	Jun 12 '26	Proposed Sale	7.26	22,000	159,720		Jun 12 10:37 AM
Dorval Allison	Director	Jun 12 '26	Proposed Sale	7.26	11,610	84,289		Jun 12 10:33 AM
Stuglik Brian M	Director	Jun 12 '26	Proposed Sale	7.26	8,100	58,806		Jun 12 10:23 AM
WILSON TROY EDWARD	Director	Jun 12 '26	Proposed Sale	7.26	10,800	78,408		Jun 12 09:58 AM
AUERBACH ALAN H	President and CEO	Jan 07 '26	Sale	5.88	18,012	105,893	7,145,951	Jan 08 08:27 PM
AUERBACH ALAN H	President and CEO	Jan 06 '26	Sale	5.84	16,938	98,986	7,163,963	Jan 08 08:27 PM
HUNT DOUGLAS M	See Remarks	Jan 07 '26	Sale	5.88	5,014	29,477	155,907	Jan 08 08:15 PM
HUNT DOUGLAS M	See Remarks	Jan 06 '26	Sale	5.84	3,973	23,218	160,921	Jan 08 08:15 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jan 07 '26	Sale	5.88	6,405	37,655	193,284	Jan 08 08:14 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jan 06 '26	Sale	5.84	4,540	26,532	199,689	Jan 08 08:14 PM
AUERBACH ALAN H	Officer	Jan 07 '26	Proposed Sale	5.88	18,012	105,893		Jan 07 04:28 PM
HUNT DOUGLAS M	Officer	Jan 07 '26	Proposed Sale	5.88	5,014	29,477		Jan 07 04:25 PM
NOUGUES MAXIMO F	Officer	Jan 07 '26	Proposed Sale	5.88	6,405	37,655		Jan 07 04:24 PM
NOUGUES MAXIMO F	Officer	Jan 06 '26	Proposed Sale	5.84	4,540	26,530		Jan 06 04:53 PM
HUNT DOUGLAS M	Officer	Jan 06 '26	Proposed Sale	5.84	3,973	23,217		Jan 06 04:45 PM
AUERBACH ALAN H	Officer	Jan 06 '26	Proposed Sale	5.84	16,938	98,979		Jan 06 04:44 PM
MILLER MICHAEL PATRICK	Director	Nov 11 '25	Sale	4.86	20,000	97,228	54,000	Nov 13 04:41 PM
MILLER MICHAEL PATRICK	Director	Nov 11 '25	Proposed Sale	4.86	20,000	97,228		Nov 12 08:29 AM
Cesano Alessandra	Director	Jul 18 '25	Sale	3.37	27,000	90,909	41,850	Jul 22 07:51 PM
Cesano Alessandra	Director	Jul 18 '25	Proposed Sale	3.37	27,000	90,909		Jul 18 04:16 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jul 08 '25	Sale	3.53	5,587	19,739	208,164	Jul 10 08:56 PM
NOUGUES MAXIMO F	Chief Financial Officer	Jul 09 '25	Sale	3.54	3,935	13,910	204,229	Jul 10 08:56 PM
HUNT DOUGLAS M	See Remarks	Jul 08 '25	Sale	3.53	4,374	15,453	168,337	Jul 10 08:52 PM
HUNT DOUGLAS M	See Remarks	Jul 09 '25	Sale	3.54	3,443	12,171	164,894	Jul 10 08:52 PM
AUERBACH ALAN H	President and CEO	Jul 08 '25	Sale	3.53	25,592	90,417	7,202,481	Jul 10 08:49 PM
AUERBACH ALAN H	President and CEO	Jul 09 '25	Sale	3.54	21,580	76,285	7,180,901	Jul 10 08:49 PM
NOUGUES MAXIMO F	Officer	Jul 09 '25	Proposed Sale	3.54	3,935	13,910		Jul 09 04:48 PM
AUERBACH ALAN H	Officer	Jul 09 '25	Proposed Sale	3.54	21,580	76,285		Jul 09 04:36 PM
HUNT DOUGLAS M	Officer	Jul 09 '25	Proposed Sale	3.54	3,443	12,171		Jul 09 04:27 PM
AUERBACH ALAN H	Officer	Jul 08 '25	Proposed Sale	3.53	25,592	90,424		Jul 08 04:41 PM
NOUGUES MAXIMO F	Officer	Jul 08 '25	Proposed Sale	3.53	5,587	19,741		Jul 08 04:39 PM
HUNT DOUGLAS M	Officer	Jul 08 '25	Proposed Sale	3.53	4,374	15,455		Jul 08 04:29 PM

Open in Screener

SINT

SINTX Technologies Inc

Jun 15 • 04:00PM ET

2.21

+0.09 4.25 %

Healthcare • Medical Devices • USA • Nano • NASD

SINT SINTX Technologies Inc daily Stock Chart

Peers: ADGM AIDX ICCM IRIX NXL PMI TRIB VVOS XAIR NUWE

| Held by: VXF DFAC

Index	-	P/E	-	EPS (ttm)	-5.64	Insider Own	20.34%	Shs Outstand	4.12M	Perf Week	6.76%
Market Cap	9.55M	Forward P/E	-	EPS next Y	-1.43	Insider Trans	1.42%	Shs Float	3.44M	Perf Month	-7.92%
Enterprise Value	10.92M	PEG	-	EPS next Q	-0.67	Inst Own	10.01%	Short Float	5.69%	Perf Quarter	-21.07%
Income	-17.61M	P/S	9.27	EPS this Y	65.21%	Inst Trans	26.42%	Short Ratio	4.08	Perf Half Y	-43.48%
Sales	1.03M	P/B	10.07	EPS next Y	33.13%	ROA	-113.12%	Short Interest	0.20M	Perf YTD	-42.75%
Book/sh	0.22	P/C	5.05	EPS next 5Y	50.66%	ROE	-311.41%	52W High	6.78 -67.40%	Perf Year	-32.42%
Cash/sh	0.44	P/FCF	-	EPS past 3/5Y	92.03% 80.47%	ROIC	-299.34%	52W Low	1.86 18.82%	Perf 3Y	-99.29%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-13.28% 11.38%	Gross Margin	0.97%	Volatility	5.46% 7.46%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	10.60	EPS Y/Y TTM	56.67%	Oper. Margin	-1121.96%	ATR (14)	0.16	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	0.70	Sales Y/Y TTM	-59.95%	Profit Margin	-1711.56%	RSI (14)	48.56	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.04	EPS Q/Q	45.64%	SMA20	0.34%	Beta	0.60	Target Price	9.33
Payout	-	Debt/Eq	3.62	Sales Q/Q	2.98%	SMA50	-7.17%	Rel Volume	0.23	Prev Close	2.12
Employees	32	LT Debt/Eq	3.03	Earnings	May 15	SMA200	-32.07%	Avg Volume	47.98K	Price	2.21
IPO	Feb 13, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	1.52% 20.00%	Trades		Volume	10,829	Change	4.25%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-13-26	Initiated	H.C. Wainwright	Buy	$10
Sep-12-19	Initiated	Ascendiant Capital Markets	Buy

Jun-03-26 09:00AM	SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) +7.69%
May-17-26 03:30PM	SINTX Technologies to Present at the LD Micro Invitational XVI Conference (Newsfile)
Mar-23-26 09:15AM	SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution (GlobeNewswire)
Mar-19-26 07:30AM	SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC Foot & Ankle Implant (GlobeNewswire)
Feb-18-26 08:30AM	SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms (GlobeNewswire)
09:00AM	Loading…
Jan-29-26 09:00AM	SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4-5 (GlobeNewswire)
Dec-08-25 09:00AM	SINTX Technologies to Participate in Sidoti & Company Investor Conference (GlobeNewswire)
Dec-01-25 08:30AM	SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride-PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants (GlobeNewswire) -21.20%
Nov-13-25 08:00AM	SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies (GlobeNewswire) -10.79%
Nov-10-25 09:40AM	Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates (Zacks) +8.87%
Nov-06-25 05:30PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-04-25 08:40AM	Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-03-25 08:00AM	SINTX Technologies Announces Launch of OsseoSculpt an Advanced Biologic for Use with SINAPTIC Foot & Ankle Osteotomy Wedge System (GlobeNewswire)
Oct-23-25 09:15AM	Integer (ITGR) Beats Q3 Earnings and Revenue Estimates (Zacks) +6.46%
Oct-20-25 07:00AM	SINTX Technologies Receives FDA Clearance for SINAPTIC Foot & Ankle Implant System (GlobeNewswire) -15.40%
12:00PM	Loading…
Oct-16-25 12:00PM	What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now? (Zacks) -5.35%
07:00AM	UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market (GlobeNewswire)
Oct-14-25 07:00AM	SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics (GlobeNewswire)
Sep-09-25 07:00AM	SINTX Technologies to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025 (GlobeNewswire) -7.63%
Sep-08-25 07:54AM	SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds (GlobeNewswire) -16.70%
07:00AM	SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent (GlobeNewswire)
Sep-03-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +15.97%
07:00AM	SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride (GlobeNewswire)
Aug-15-25 07:00AM	SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition (GlobeNewswire)
Aug-07-25 06:35PM	Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +7.64%
Aug-04-25 07:00AM	SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates (GlobeNewswire) +11.25%
Jul-22-25 05:15PM	Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Top Estimates (Zacks) -5.76%
07:00AM	SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices (GlobeNewswire)
Jun-24-25 08:30AM	SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market (GlobeNewswire)
Jun-12-25 09:00AM	SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors (GlobeNewswire) +6.46%
07:00AM	Loading…
May-22-25 07:00AM	SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market (GlobeNewswire) -7.57%
May-15-25 07:05AM	SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization (GlobeNewswire)
Apr-03-25 08:00AM	SINTX Technologies Announces Strategic Changes to Board of Directors (GlobeNewswire)
Mar-19-25 05:23PM	Sintx Technologies files to sell 3.01M shares of common stock for holders (SeekingAlpha)
08:00AM	SINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine Fusion (GlobeNewswire)
Mar-17-25 08:00AM	Sintx Technologies Announces Board Chairman Transition (GlobeNewswire) -8.77%
Feb-26-25 08:00AM	SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules (GlobeNewswire) -19.63%
Feb-20-25 06:15AM	SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market (GlobeNewswire)
Feb-19-25 06:00AM	SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial (GlobeNewswire) +70.92%
Dec-17-24 06:00AM	SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications (GlobeNewswire)
Nov-21-24 06:00AM	SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment (GlobeNewswire) +15.59%
Nov-19-24 06:49AM	Sintx Technologies Initiates Stock Repurchase Program (TipRanks)
06:00AM	SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer (GlobeNewswire)
Nov-18-24 06:00AM	SINTX Technologies Announces Stock Repurchase Program (GlobeNewswire) +55.88%
Nov-14-24 06:00AM	SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 (GlobeNewswire)
Oct-01-24 08:00AM	SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T (GlobeNewswire)
Sep-20-24 08:00AM	Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: "Innovations in Ceramic Manufacturing: The Role of 3D Printing" (GlobeNewswire)
Sep-19-24 08:00AM	SINTX Announces Completion of $3.1 Million ATM Equity Public Offering (GlobeNewswire)
Sep-09-24 08:00AM	SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial (GlobeNewswire) +54.61%
Sep-05-24 08:00AM	SINTX Provides Strategic Update: Significant Cost Reductions, Extended Cash Runway, and Exploration of Strategic Partnerships (GlobeNewswire)
Aug-13-24 10:54PM	SINT Stock Earnings: SINTX Technologies Beats Revenue for Q2 2024 (InvestorPlace)
Aug-06-24 09:00AM	SINTX Technologies Announces Appointment of Eric K. Olson as Chief Executive Officer (GlobeNewswire)
Jun-18-24 09:00AM	SINTX Technologies to Explore Strategic Opportunities (GlobeNewswire)
Jun-12-24 09:00AM	SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement (GlobeNewswire)
Jun-06-24 09:00AM	SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology (GlobeNewswire) -11.33%
May-29-24 09:00AM	SINTX TECHNOLOGIES SIGNS AGREEMENT TO ENTER KOREAN TECHNICAL CERAMICS SECTOR (GlobeNewswire) -15.73%
May-23-24 09:00AM	SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024 (GlobeNewswire) -13.50%
May-22-24 07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-20-24 07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +32.82%
May-15-24 08:36AM	Castellum (CTM) Stock Down 16% Today? (InvestorPlace) +132.00%
08:05AM	Why Is Sintx Technologies (SINT) Stock Up 113% Today? (InvestorPlace)
07:57AM	Top Premarket Gainers (MT Newswires)
07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-14-24 09:52AM	SINT Stock Earnings: SINTX Technologies Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +41.75%
Apr-29-24 09:14AM	SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT (GlobeNewswire) +34.90%
Apr-03-24 09:00AM	SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock (GlobeNewswire) -43.77%
Mar-29-24 04:00PM	SINTX Technologies Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Mar-28-24 06:52AM	SINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 09:05AM	Why Is Sintx Technologies (SINT) Stock Down 31% Today? (InvestorPlace) -45.95%
09:00AM	SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock (GlobeNewswire)
Mar-22-24 08:30AM	SINTX Technologies Announces Proposed Public Offering of Common Stock (GlobeNewswire) -31.99%
Feb-21-24 09:00AM	SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET (GlobeNewswire)
Feb-02-24 02:33PM	SINTX Technologies Announces Closing of $4.0 Million Public Offering (GlobeNewswire)
Jan-31-24 09:20AM	SINTX Technologies Announces Pricing of $4.0 Million Public Offering (GlobeNewswire) -34.50%
07:59AM	Why Is SINTX Technologies (SINT) Stock Up 52% Today? (InvestorPlace)
Jan-30-24 04:01PM	SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY (GlobeNewswire) -13.69%
Jan-23-24 09:00AM	SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE (GlobeNewswire)
Jan-04-24 09:00AM	SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO (GlobeNewswire)
Nov-07-23 09:00AM	SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS (GlobeNewswire) -8.47%
Oct-11-23 09:00AM	SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants (GlobeNewswire)
Aug-31-23 03:26PM	11 ChatGPT Penny Stock Picks (Insider Monkey)
Aug-17-23 09:00AM	3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS (GlobeNewswire) -9.24%
Feb-14-23 09:00AM	SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL (GlobeNewswire) -11.81%
Feb-10-23 01:52PM	SINTX Technologies Announces Closing of $12.0 Million Public Offering (GlobeNewswire) -9.93%
Feb-07-23 09:05PM	SINTX Technologies Announces Pricing of $12.0 Million Public Offering (GlobeNewswire) -18.60% -45.87%
Jan-19-23 09:00AM	SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update (GlobeNewswire) +11.82%
Jan-06-23 09:00AM	SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT (GlobeNewswire)
Dec-21-22 09:00AM	SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING (GlobeNewswire) +57.16%
Dec-19-22 09:00AM	SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022 (GlobeNewswire)
Nov-16-22 05:27AM	Sintx Technologies Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Oct-26-22 09:00AM	SINTX TECHNOLOGIES AWARDED MULTI-YEAR DARPA CONTRACT TO DEVELOP CMCs AND HIGH TEMPERATURE COATINGS FOR TURBINE ENGINES (GlobeNewswire) +6.79%
Oct-13-22 08:30AM	SINTX Technologies, Inc. Announces Subscriptions of Approximately $4.7 Million from its Rights Offering (GlobeNewswire) -8.22%
Oct-11-22 09:00AM	SINTX TECHNOLOGIES RECEIVES PRODUCTION ORDER FOR AEROSPACE COMPONENTS (GlobeNewswire) -5.28%
Oct-04-22 11:05AM	SINTX ANNOUNCES NEW ANTIBACTERIAL BIOMEDICAL PATENTS AND EXPANSION OF INTELLECTUAL PROPERTY PORTFOLIO (GlobeNewswire) -7.23%
Sep-29-22 09:00AM	NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE (GlobeNewswire)
Sep-27-22 09:00AM	SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS (GlobeNewswire) -6.31%
Sep-26-22 09:00AM	SINTX TECHNOLOGIES ANNOUNCES COMMENCEMENT OF RIGHTS OFFERING SUBSCRIPTION PERIOD AND UPDATED TERMS AND DATES OF ITS PREVIOUSLY ANNNOUNCED RIGHTS OFFERING (GlobeNewswire) -16.75%
Sep-12-22 09:00AM	SINTX TECHNOLOGIES INFORMS STOCKHOLDERS OF KEY DATES AND TERMS RELATED TO ANNOUNCED RIGHTS OFFERING (GlobeNewswire)
Sep-08-22 09:00AM	SINTX ANNOUNCES SUCCESSFUL FDA 510(k) PRE-SUBMISSION MEETING FOR SILICON NITRIDE-PEEK COMPOSITE SPINE IMPLANTS (GlobeNewswire)
Aug-23-22 09:00AM	Oxford Performance Materials and SINTX Technologies Collaboration Yields Major Breakthrough in Orthopedic & Dental Coatings (GlobeNewswire) -5.45%

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in December 1996 and is headquartered in Salt Lake City, UT.

CEO & Chairman of the BoardMr. Eric K. Olson

Chief Financial OfficerMr. Kevin Trask

Chief Investment Officer & DirectorMr. Gregg Richard Honigblum

PresidentMr. Ryan Elmore

Chief Legal OfficerMr. Kevin J. Ontiveros Esq.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lyons Christopher Michael	Director	Mar 02 '26	Buy	2.90	7,534	21,849	8,292	Mar 10 09:00 AM
Lyons Christopher Michael	Director	Feb 25 '26	Buy	2.96	758	2,244	758	Mar 10 09:00 AM
MOYES JAY M	Director	Feb 23 '26	Buy	2.91	1,000	2,910	4,000	Feb 25 09:00 AM
Anderson Mark Lewis	Director	Feb 18 '26	Buy	3.02	3,000	9,060	18,000	Feb 19 09:00 AM
Honigblum Gregg R.	Chief Investment Officer	Dec 08 '25	Buy	4.26	8,200	34,896	201,067	Dec 09 08:00 AM
Honigblum Gregg R.	Chief Investment Officer	Dec 05 '25	Buy	3.93	65,000	255,350	139,000	Dec 08 08:00 AM
Honigblum Gregg R.	Chief Investment Officer	Nov 07 '25	Buy	3.19	10,000	31,900	74,000	Nov 10 08:00 AM
Olson Eric K.	President and CEO	Oct 20 '25	Buy	3.40	5,800	19,720	30,775	Oct 21 07:00 AM
MOYES JAY M	Director	Aug 26 '25	Buy	3.59	3,000	10,756	3,000	Aug 27 08:00 AM
Honigblum Gregg R.	Chief Investment Officer	Aug 26 '25	Buy	3.70	50,000	185,000	64,000	Aug 27 08:00 AM
Olson Eric K.	President and CEO	Aug 22 '25	Buy	3.58	10,475	37,470	24,975	Aug 25 05:14 PM
Anderson Mark Lewis	Director	Jun 18 '25	Buy	3.30	10,000	33,000	15,000	Jun 23 09:00 AM

PBYI

Puma Biotechnology Inc

SINT

SINTX Technologies Inc

Upgrade your Finviz experience